Trial intelligence / Profile preview

Clotrimazole for asymptomatic candidiasis in pregnancy to reduce preterm birth

ACTRN12609001052224Phase 4Completed

Sponsor
Royal North Shore Hospital
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of clotrimazole in candidiasis (2 arms), sponsored by Royal North Shore Hospital. Primary endpoint: Preterm birth less than 37 weeks. Started Jun 2008; status: completed.

02

Drugs

clotrimazole
03

Conditions

candidiasis

Beyond the preview

Go deeper on ACTRN12609001052224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12609001052224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call